Geoffrey E. Harris insider trades: Vyant Bio (VYNT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geoffrey reports to the SEC
and 1 more company
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | VYNT | ↓ Sell | 765 | $1.33 | $1K | Direct | Nov 22, 2022 (4d) |
| Jan 14, 2019 | CGIX | ↑ Buy | 100,000 | $0.23 | $23K | Direct | Jan 16, 2019 (2d) |
| Dec 6, 2017 | MYND | ↑ Buy | 4,552 | $3.81 | $17K | Direct | Dec 7, 2017 (1d) |
| May 16, 2017 | CGIX | ↑ Buy | 2,500 | $3.75 | $9K | Direct | May 16, 2017 (0d) |
| Dec 14, 2016 | CGIX | ↑ Buy | 2,500 | $1.50 | $4K | Direct | Dec 14, 2016 (0d) |
| Nov 14, 2016 | CGIX | ↑ Buy | 5,000 | $1.55 | $8K | Direct | Nov 16, 2016 (2d) |
| May 14, 2015 | CGIX | ↑ Buy | 5,000 | $10.79 | $54K | Direct | May 18, 2015 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Geoffrey E. Harris's insider trades
Geoffrey E. Harris is a director at Vyant Bio (VYNT). Since May 14, 2015, Geoffrey has reported 6 open-market purchases worth $115K and 1 sale worth $1K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), other transactions (1 filing), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VYNT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.